Amanote Research
Register
Sign In
Interplay of Mevalonate and Hippo Pathways Regulates RHAMM Transcription via YAP to Modulate Breast Cancer Cell Motility
Proceedings of the National Academy of Sciences of the United States of America
- United States
doi 10.1073/pnas.1319190110
Full Text
Open PDF
Abstract
Available in
full text
Categories
Multidisciplinary
Date
December 23, 2013
Authors
Z. Wang
Y. Wu
H. Wang
Y. Zhang
L. Mei
X. Fang
X. Zhang
F. Zhang
H. Chen
Y. Liu
Y. Jiang
S. Sun
Y. Zheng
N. Li
L. Huang
Publisher
Proceedings of the National Academy of Sciences
Related search
Angiomotin Regulates Prostate Cancer Cell Proliferation by Signaling Through the Hippo-Yap Pathway
Oncotarget
Oncology
Energy Stress Regulates the Hippo-Yap Pathway
Cancer Discovery
Oncology
OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ
Molecular Cell
Cell Biology
Molecular Biology
TRPS1 Shapes YAP/TEAD-dependent Transcription in Breast Cancer Cells
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Hippo Signaling Regulates Drosophila Intestine Stem Cell Proliferation Through Multiple Pathways
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
LIFR Is a Breast Cancer Metastasis Suppressor Upstream of the Hippo-Yap Pathway and a Prognostic Marker
Nature Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Circ_0001667 Promotes Breast Cancer Cell Proliferation and Survival via Hippo Signal Pathway by Regulating TAZ
Cell and Bioscience
Biochemistry
Genetics
Molecular Biology
S100A4 Regulates Cell Motility and Invasion in an in Vitro Model for Breast Cancer Metastasis
British Journal of Cancer
Cancer Research
Oncology
Hyaluronan-Mediated Motility Receptor (RHAMM; CD168)
Science-Business eXchange